RBCC News 0.1430 Rainbow Coral Corp (RBCC)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rainbow Coral Corp (RBCC) 0.1430 $RBCC

RBCC and n3D partnership plans to raise additional capital to market and develop its 3D bioprinting technology
M2 - Thu Apr 10, 6:51AM CDT
US-based bioscience solutions company, Rainbow Coral (OTCBB:RBCC), said on Wednesday that it plans to sign new finance partners to market and develop its 3D bioprinting technology worldwide in conjunction with its joint venture partner, Nano3D Biosciences (n3D).

RBCC and n3D Seek Out Additional Capital
Business Wire - Wed Apr 09, 4:00AM CDT
Rainbow Coral Corp. (OTCBB: RBCC) and its joint venture partner, Nano3D Biosciences (n3D) are seeking out new finance partners to market and develop their 3D bioprinting technology worldwide.

Netflix Shares fall as Amazon Releases Fire TV; CEMEX gains on Cement Merger Talks
ACCESSWIRE - Sun Apr 06, 11:12PM CDT
CEMEX, S.A.B. de C.V. (NYSE: CX) - For an in-depth report on CEMEX, S.A.B. de C.V. follow: www.BullTrends.com/stockquote/CX

Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
Business Wire - Thu Apr 03, 4:00AM CDT
By substantially increasing its investment in biotech innovators Nano3D Biosciences, Rainbow Coral Corp. (OTCBB: RBCC) has positioned itself on the front lines of a bioprinting revolution poised to forever alter the possibilities of healthcare.

RBCC to Increase Investment in 3D Bioprinting Innovation
Business Wire - Tue Mar 25, 9:18AM CDT
As demand for new cellular research innovations continues to soar worldwide, Rainbow Biosciences, the biotechnology division of Rainbow Coral Corp. (OTCBB: RBCC), is increasing its investment in the marketing and development of a breakthrough 3D bioprinting technology.

RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry
Business Wire - Thu Mar 06, 4:00AM CST
A new research publication lists Rainbow Coral Corp. (OTCBB: RBCC) Nano3D Biosciences (n3D) as a leading stakeholder in an industry forecast to be worth $10 billion by 2030.

RBCC Increases Foothold in 3D Bioprinting Market
Business Wire - Wed Feb 26, 6:49AM CST
With analysts around the globe predicting incredible growth in the 3D printing sector in the coming years, Rainbow Coral Corp. (OTCBB: RBCC) announced today that it will extend its investment position in Nano3D Biosciences (n3D), a company on the cutting edge of the 3D bioprinting revolution.

RBCC: New Innovations Spur Demand for 3D Printing in Medicine
Business Wire - Thu Feb 20, 4:00AM CST
As Rainbow Coral Corp. (OTCBB: RBCC) works to market and develop an innovative new 3D bioprinting system, new 3D printing innovations are generating massive new demand for the technology from patients and doctors alike in the medical industry.

New Product Puts RBCC on Leading Edge of Organ Regeneration Research
Business Wire - Tue Feb 18, 4:00AM CST
The 3D printing of functional human organs could be a reality within the next decade, and Rainbow Coral Corp. (OTCBB: RBCC) is helping to lead the bioprinting revolution now underway.

RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion
Business Wire - Thu Feb 06, 4:00AM CST
Rainbow Bioscience, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC), announced today that it is seeking out new capital partners to help expand marketing and streamline development on the BiO Assay, a 3D bioprinting system poised to potentially revolutionize the drug development industry.

RBCC: 3D Bioprinting Tech Ushers in Future of Medicine
Business Wire - Mon Feb 03, 7:40AM CST
The BiO Assay, a magnetic 3D bioprinting system being marketed and developed by Rainbow Coral Corp. (OTCBB: RBCC) and joint venture partner Nano3D Biosciences (n3D), is the first designed specifically for rapid, high-volume drug screening--ushering in an exciting new era in medicine.

RBCC Develops Innovations in White-Hot 3D Bioprinting Sector
Business Wire - Mon Jan 27, 3:00AM CST
As global demand for new innovations in the booming 3D printing industry grows exponentially by the day, Rainbow Coral Corp. (OTCBB: RBCC) is preparing to capitalize with groundbreaking new products for the 3D marketplace.

RBCC Explores New Contacts in Personalized Medicine and Drug Delivery
Business Wire - Wed Jan 22, 6:53AM CST
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that the company's executive leadership is now pursuing potentially lucrative partnerships with contacts made at last week's Biotech Showcase in San Francisco.

RBCC Moves to the Front Lines of the 3D Bioprinting Revolution
Business Wire - Mon Jan 20, 4:00AM CST
Rainbow Coral Corp. (OTCBB: RBCC) is well-positioned to capitalize on the revolution in medicine being spurred on by 3D printing technology thanks to the innovative BiO Assay, a new 3D bioprinting system developed by RBCC's joint venture partner, Nano3D Biosciences (n3D).

RBCC Prepares Big Push Into Booming 3D Bioprinting Market
Business Wire - Thu Jan 16, 4:00AM CST
Thanks to new technology innovations pioneered by its partners at Nano3D Biosciences (n3D), Rainbow Coral Corp. (OTCBB: RBCC) is planning a major push into the skyrocketing 3D bioprinting market in 2014.

RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase
Business Wire - Wed Jan 15, 3:59AM CST
Rainbow Coral Corp. (OTCBB: RBCC) joint venture partner Therakine, Ltd., presented its new novel drug-delivery technology at one of the world's largest and most important gatherings of life sciences investors this week at the Biotech Showcase in San Francisco.

RBCC Opens Talks with Top Innovators at Major Biotech Conference
Business Wire - Tue Jan 14, 7:56AM CST
The executive leadership of Rainbow Coral Corp. (OTCBB:RBCC), a biotechnology company, is spending its week meeting with potential partners and innovators in San Francisco at one of the largest and most important biotechnology conferences in the world.

RBCC Partner n3D Commercializes New 3D Bioprinting Technology
Business Wire - Mon Jan 13, 4:52AM CST
Rainbow Coral Corp.'s (OTCBB: RBCC) joint venture partner, Nano3D Biosciences (n3D), has developed the first commercially available 3D bioprinting system designed for high throughput and high-content drug screening, and the global market potential for the device points to very bright future for the company.

RBCC to Scout New Innovations at Biotech Showcase
Business Wire - Thu Jan 02, 2:59AM CST
Executive leadership from Rainbow Coral Corp. (OTCBB: RBCC), a fast-rising biotechnology company, will scout for new innovations and potential partnerships this month at the sixth annual Biotech Showcase in San Francisco.

RBCC and Therakine Initiate Phase II of Drug Delivery Development
Business Wire - Thu Dec 12, 4:00AM CST
Rainbow Coral Corp. (OTCBB: RBCC) and its joint venture partner, Therakine, Ltd., are pleased to announce that they have reached a major new milestone in the development of a revolutionary new drug delivery technology. This week, the companies reached terms to initiate Phase II of research and analysis on a new injectable, sustained-release technology poised to vastly improve patients' use of a crucial drug in the fight against drug and alcohol dependence.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 131

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 187

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 69

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 122

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
XKIG Bolsters Northwest with Jensen's Acquisition

Updated Category News Views 44

Stepping Up the Game in the Pacific Northwest Well, here we see another classic example of a shrewd move in the infrastructure sector. XKIG, a name known to those who keep an eye on critical infrastructure services for utilities, has decided to widen its footprint with a strategic grab of Jensen's Tree Service, Inc. They’re setting up shop even deeper in the Pacific...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 127

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 44

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading

Top 5 Most Recently Viewed Articles

New Research Grants Support Diet Impact on Health Outcomes

Updated Category News Views 85

New Research Grants Empower Understanding of Diet and Health Healthcare technology company Komodo Health has recently announced the recipients of its 2024 Diet-Related Health (DRH) grants. These grants are aimed at advancing research that explores the pivotal influence of diet on various health outcomes. Funded by the Robert Wood Johnson Foundation (RWJF), the DRH program...

Continue Reading
Innovative Cardiology Care with Dr. Butkevich's Hybrid Choice™

Updated Category News Views 118

Dr. Alexander Butkevich Introduces Hybrid Choice™ Concierge Program Patients in the Houston area can now access a unique cardiology service from Dr. Alexander Butkevich, MD, thanks to Concierge Choice Physicians. This innovative program provides enhanced connectivity and personalized care adjustments, catering to the evolving needs of patients. The Unique Benefits of...

Continue Reading
Revolutionizing Cryptocurrency with ALR MINER's AI Cloud Service

Updated Category News Views 274

Revolutionizing Cryptocurrency Mining ALR MINER has emerged as a pioneering force in the cryptocurrency world by launching a groundbreaking zero-cost AI cloud mining platform. This innovative approach gives users the opportunity to earn cryptocurrencies like Bitcoin, Ethereum, Dogecoin, and Ripple without any upfront costs, reshaping the way mining is perceived and...

Continue Reading
Instacart Positioned Well Amid Competition with Major Rivals

Updated Category News Views 279

Instacart's Competitive Landscape Instacart (NASDAQ:CART) has made a notable mark in the online grocery delivery sector, and analysts from Goldman Sachs believe its stock is already reflecting the ongoing competition. Despite challenges from giants like Amazon, Uber, and DoorDash, there are reasons to maintain a bullish outlook on Instacart. Supporting Recommendation from...

Continue Reading
Daily Mango Benefits: Heart Health Insights for Women

Updated Category News Views 238

Exploring Mango's Heart Health Benefits Mangos have long been celebrated for their vibrant flavor and nutritional perks. Recent studies now emerge, shedding light on the potential heart and metabolic health benefits of daily mango consumption, particularly for postmenopausal women. This demographic faces unique challenges as they navigate changes in their bodies and...

Continue Reading